LEP and metabolic dysfunction-associated steatotic liver disease: Recently, a protective effect of SELM on non-alcoholic fatty liver disease, cytotoxic effect of recombinant SELM on human glioblastoma cells, and SELM’s promotion of leptin signaling and thioredoxin activity have been reported44–46.